[Present aspects of bone marrow lesions due to drugs (author's transl)].
D000741:Anemia, Aplastic / Q000139:chemically induced / Q000453:epidemiology; D001855:Bone Marrow Diseases / Q000139:chemically induced* / Q000453:epidemiology; D002701:Chloramphenicol / Q000009:adverse effects / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions; D005860:Germany, West; D006046:Gold / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010113:Oxyphenbutazone / Q000009:adverse effects / Q000627:therapeutic use; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use; D013548:Sweden; D014481:United States
D013449:Sulfonamides; D010672:Phenytoin; D002701:Chloramphenicol; D006046:Gold; D010653:Phenylbutazone; D010113:Oxyphenbutazone
Aktuelle Aspekte arzneimittelbedingter Knochenmarkschäden